---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42765671.md"
description: "$Amgen(AMGN.US)'s weight loss pipeline and $Intellia Therap(NTLA.US)'s gene editing represent two pharmaceutical paradigms, old and new, with data readout windows both scheduled for the second half of the year🤔"
datetime: "2026-07-17T10:52:44.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42765671.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42765671.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42765671.md)
author: "[市场是对的我才是错的](https://longbridge.com/en/profiles/25865095.md)"
---

# $Amgen(AMGN.US)'s weight loss pipeline and $Intell…


### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [NTLA.US](https://longbridge.com/en/quote/NTLA.US.md)